Cannabinoid Testing Growth Opportunity to expand service offering from 10 cannabinoid potency profiling to include terpene testing via Gas Chromatography as of late spring 2019, enabling broader analytical capabilities for cannabis product developers and breeders.

Private Lab Partnerships Current collaboration model with private labs, licensed cannabis labs, and state agencies suggests potential for consulting, quality systems outsourcing, and method standardization services to strengthen reliability for customers and regulators.

Small Team Agility Small team size (2-10 employees) indicates a need for scalable, easily deployable services such as cloud-based data reporting, automated QA workflows, and quick-turnaround testing for high-value, high-quality results.

Quality Assurance Focus Emphasis on monitoring methods and procedures aligns with demand for compliant, auditable testing data; opportunity to offer training, SOP development, and regulatory readiness packages for clinical, research, and product development clients.

Revenue Opportunities Annual revenue in the multi-million range signals potential as a target for premium testing contracts, volume-based pricing, and expanded service lines to support patients, clinicians, breeders, and product developers seeking reliable lab results.